Proteolytic cleavage of recombinant two-chain factor VIII during cell culture production is mediated by protease(s) from lysed cells. The use of pulse labelling directly in production medium
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
During the production by mammalian cells of recombinant factor VIII from which the B domain was deleted (rFVIII), proteolytic cleavages in the C-terminal part of the heavy chain were observed (Kjalke et al., 1995). By radioactive pulse labelling it was investigated whether the cleavages took place inside the cells during protein synthesis or after release in the medium. The rFVIII-producing CHO (Chinese hamster ovary) cells were cultured in the presence of 35S-methionine and then the cell lysate and the conditioned media were immunoprecipitated and analyzed by electrophoresis. By pulse labelling and chasing for various time periods, it was shown that the cleavages only took place after secretion of the protein from the cells. Adding cell lysate to uncleaved rFVIII caused cleavage of the heavy chain, as seen by loss of binding to a monoclonal antibody specific for intact rFVIII, indicating that the cleavage was performed by proteinase(s) released from the lysed cells. By incubating intact rFVIII with the multicatalytic proteinase (proteasome) present in cytoplasm and nucleus of eukaryotic cells, loss of binding to the monoclonal antibody was observed. This indicates that the multicatalytic proteinase, released from lysed rFVIII producing cells, could be responsible for the cleavage of rFVIII. Among several protease inhibitors tested, only bacitracin was found to diminish the extent of cleavage. Phosphatidylserine also protected rFVIII against cleavage, probably by binding to rFVIII.
- Andersson L-O and Brown JE (1981) Interaction of factor VIII — von Willebrand factor with phospholipid vesicles. Biochem. J. 200: 161–167.
- Ezban M, Chapman B, Petersen J, Hansen K, Rasmussen PB, Thomsen J, Kjalke M and Kongerslev L (1993) Characterization of recombinant human two-chain factor VIII. Thromb. Hemostasis 69: 1088.
- Froud SJ, Clements GJ, Doyle ME, Harris ELV, Lloyd C, Murray P, Preneta PE, Stephens PE, Thomsen S and Yarranton GT: (1991) The development of a process for the production of HIV1 GP120 from recombinant cell lines. In: Spier RE et al. (eds) Production of Biologicals from animal cells in culture, pp. 110–114, Butterworth-Heinemann, Oxford.
- Gilbert GE and Drinkwater D (1993) Specific membrane binding of factor VIII is mediated by O-phospho-L-serine, a moiety of phosphatidylserine. Biochemistry 32: 9577–9585. CrossRef
- Hames BD (1990) Preparation and electrophoresis of polyacrylamide gels. In: Hames BD and Rickwood D. (eds) Gel electrophoresis of proteins. A practical approach, pp. 30–50, Oxford University Press, Oxford.
- Hosoi S, Miyaji H, Satoh M, Kurimoto T, Mihara A, Fujiyoshi N, Itoh S and Sato S: (1991) Optimization of cell culture conditions for production of biologically active proteins. Cytotechnology 5: S17–34. CrossRef
- Kjalke M, Heding A, Talbo G, Persson E, Thomsen J and Ezban M (1995) Amino acid residues 721–729 are required for full factor VIII activity. Eur. J. Biochem: 234: 773–779. CrossRef
- Kobayashi N, Takenouchi T, Endo S and Munekata E (1992) 1H-NMR study of the conformation of bacitracin A in aqueous solution. FEBS Lett. 305:105–109. CrossRef
- Kratje RB, Lind W and Wagner R (1994) Evaluation of the proteolytic potential of in vitro-cultivated hybridoma and recombinant mammalian cells. J. of Biotechnology: 32: 107–125. CrossRef
- Mäkinen KK (1972) Inhibition by bacitracin of some hydrolytic enzymes. Int. J. Protein Res. 4: 21–28.
- McMullen BA, Fujikawa K, Davie EW, Hedner U and Ezban M (1995) Location of disulfide bonds and free cysteines in the heavy and light chains of recombinant human factor VIII (antihemophilic factor A). Protein Sci. 4, 740–746. CrossRef
- Mizunaga T, Katakura Y, Miura T and Maruyama Y (1990) Purification and charactirization of yeast protein disulfide isomerase. J. Biochem. 108, 846–851.
- Orlowski M (1990) The multicatalytic proteinase complex, a major extralysosomal proteolytic system. Biochemistry 29: 10289–10297. CrossRef
- Rasmussen PB, Nordfang O, Hansen K, Kongerslev L and Ezban M (1993) Recombinant two-chain factor VIII obtained in high amounts at decreased temperature. Thromb. Haemost. 69: 1086.
- Rivett AJ (1993) Proteasomes: multicatalytic proteinase complexes. Biochem. J. 291: 1–10.
- Roth RA (1981) Bacitracin: An inhibitor of the insulin degrading activity of glutathione-insulin transhydrogenase. Biochem. Biophys. Res. Commun. 98, 431–438. CrossRef
- Toscano WA and Storm DR (1982) Bacitracin. Pharmac. Ther. 16: 199–210. CrossRef
- Urlaub G, Mitchell PJ, Kas E, Chasin LA, Funanage VL, Myoda TT and Hamlin J. (1986) Effect of gamma rays at the dihydrofolate reductase locus: deletions and inversions. Somatic Cell and Molecular Genetics 12: 555–566. CrossRef
- Varandani PT, Shroyer LA and Nafz MA (1972) Sequential degradation of insulin by rat liver homogenates. Proc. Natl. Acad. Sci. USA 69, 1681–1684. CrossRef
- Proteolytic cleavage of recombinant two-chain factor VIII during cell culture production is mediated by protease(s) from lysed cells. The use of pulse labelling directly in production medium
Volume 24, Issue 3 , pp 227-234
- Cover Date
- Print ISSN
- Online ISSN
- Kluwer Academic Publishers
- Additional Links
- CHO cells
- multicatalytic proteinase complex
- protease inhibitors
- pulse labelling
- recombinant coagulation factor VIII
- Industry Sectors